Installation
About
Chooses subgroup specific optimal doses in a phase I dose finding clinical trial allowing for subgroup combination and simulates clinical trials under the subgroup specific time to event continual reassessment method. Chapple, A.G., Thall, P.F. (2018) doi:10.1002/pst.1891.
Key Metrics
Downloads
| Last 24 hours | 0 -100% |
| Last 7 days | 28 -67% |
| Last 30 days | 236 +22% |
| Last 90 days | 681 -11% |
| Last 365 days | 3.019 -37% |